Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 697947109 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Kaupinen Wes
13D
|
14.6% |
12/20/2024
Event 12/13/2024
|
||
| Kaupinen Wes | 14.6% | |||
| Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019 | 6.9% | |||
| Christine L. Kaupinen | 13.9% | |||
| Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019 | 6.9% | |||
| Michael Christopher | 6.9% | |||
|
Suvretta Capital Management, LLC
13G/A
|
7.4% |
11/13/2025
Event 9/30/2025
|
||
| Suvretta Capital Management, LLC | 7.4% | |||
| Averill Master Fund, Ltd. | 6.5% | |||
| Aaron Cowen | 7.4% | |||
| Prudential Financial Inc 13G | 6.7% |
8/10/2026
Event 6/30/2026
|
||
| Jennison Associates LLC 13G | 6.7% |
8/3/2026
Event 6/30/2026
|
||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
|
6.0% |
2/13/2026
Event 12/31/2025
|
||
| Frazier Life Sciences Public Fund, L.P. | 6.0% | |||
| FHMLSP, L.P. | 6.0% | |||
| FHMLSP, L.L.C. | 6.0% | |||
| Frazier Life Sciences X, L.P. | 0% | |||
| FHMLS X, L.P. | 0% | |||
| FHMLS X, L.L.C. | 0% | |||
| Frazier Life Sciences XI, L.P. | 0.1% | |||
| FHMLS XI, L.P. | 0.1% | |||
| FHMLS XI, L.L.C. | 0.1% | |||
| Frazier Life Sciences XII, L.P. | 0% | |||
| FHMLS XII, L.P. | 0% | |||
| FHMLS XII, L.L.C. | 0% | |||
| James N. Topper | 0% | |||
| Patrick J. Heron | 0% | |||
| BlackRock, Inc. 13G | 5.7% |
7/29/2026
Event 6/30/2026
|
||
|
First Light Asset Management, LLC
13G/A
|
5.3% |
8/14/2026
Event 6/30/2026
|
||
| First Light Asset Management, LLC | 5.3% | |||
| Mathew P. Arens | 5.3% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (3) | ||||
|
Biotechnology Value Fund L P
13G/A
|
4.7% |
8/14/2026
Event 6/30/2026
|
||
| Biotechnology Value Fund L P | 2.5% | |||
| BVF I GP LLC | 2.5% | |||
| Biotechnology Value Fund II LP | 1.9% | |||
| BVF II GP LLC | 1.9% | |||
| Biotechnology Value Trading Fund OS LP | 0.3% | |||
| BVF Partners OS Ltd. | 0.3% | |||
| BVF GP Holdings LLC | 4.3% | |||
| BVF Partners L P/IL | 4.7% | |||
| BVF Inc/IL | 4.7% | |||
| Lampert Mark N | 4.7% | |||
|
Samsara BioCapital, L.P.
13G/A
|
3.1% |
8/14/2025
Event 6/30/2025
|
||
| Samsara BioCapital, L.P. | 3.1% | |||
| Samsara BioCapital GP, LLC | 3.1% | |||
| Srinivas Akkaraju | 3.1% | |||
|
Dellora Investments LP
13G/A
|
1.3% |
12/17/2024
Event 12/13/2024
|
||
| Dellora Investments Master Fund LP | 1.1% | |||
| Dellora Investments LP | 1.3% | |||
| Kevin Pyun | 1.3% | |||